The effects of dexamethasone vs low doses of propofol infusion on postoperative nausea and vomiting in tympanoplasty surgery: A randomized, placebo-controlled, double-blinded study; [Timpanoplasti cerrahisinde postoperatif bulantı ve kusmaya deksametazon ile düşük doz propofol infüzyonunun etkilerinin karşılaştırılması: Randomize, plasebo-kontrollü, çift kör çalışma]

ArticleAçık Erişim

Özet

This prospective study investigated the effects of dexamethasone and low-dose propofol infusion on postoperative nausea and vomiting in 90 patients undergoing tympanoplasty. The dexamethasone group (Group D) received 8 mg dexamethasone and the control group (Group C) 2 ml saline 15 min before the end of surgery, while the propofol group (Group P) received ıntrave-nous propofol infusion at a dose of 20 mcg/kg/min throughout surgery following induction of anaesthesia. Incidence rates and severity of nausea-vomiting and antiemetic requirements were recorded throughout the first postoperative 24 hours. Between hours 0 and 2, any incidence of postoperative nausea and vomiting was not observed in 23 (76.7%) patients in Group P, 17 (56.7%) in Group D and 8 (26.7%) in Group C. Differences were observed between the groups in hours 0-2 and 2-8 in terms of verbal descriptive scale values for postoperative nausea and vomiting (p<0.01 and p=0.004, respectively). Total incidence rates of postoperative nausea and vomiting at hours 2-8 h were 10.0% (n=3) in Group P, 36.7% (n=11) in Group D and 53.3% (n=16) in Group C, the difference being statistically significant in favour of Group P (p=0.032). At 0-24. hrs, the number of patients vomiting, despite treatment, were lower in Groups P and D (n=4, 13.3% and n=5, 16.7%, respectively) compared to Group C (n=14, 46.7%) (p=0.005). Antiemetic use was higher in Group C than in Groups D and P (p=0.001). Intraoperative low-dose propofol infusion is as effective as dexamethasone in reducing the incidence and severity of postoperative nausea and vomiting, as well as reducing post-tympanoplasty antiemetic requirements. © 2017, Logos Medical Publishing. All rights reserved.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/14930Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.5222/mmj.2017.085Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorÖzmen, Özgür
dc.contributor.authorBingöl, Fatih
dc.contributor.authorArslan, Zakir
dc.contributor.authorÖzel Bİngöl, Buket
dc.date.accessioned2026-10-18T20:29:43.394688464Z
dc.date.available2026-10-18T20:29:43.394688464Z
dc.date.issued2017
dc.description.abstractThis prospective study investigated the effects of dexamethasone and low-dose propofol infusion on postoperative nausea and vomiting in 90 patients undergoing tympanoplasty. The dexamethasone group (Group D) received 8 mg dexamethasone and the control group (Group C) 2 ml saline 15 min before the end of surgery, while the propofol group (Group P) received ıntrave-nous propofol infusion at a dose of 20 mcg/kg/min throughout surgery following induction of anaesthesia. Incidence rates and severity of nausea-vomiting and antiemetic requirements were recorded throughout the first postoperative 24 hours. Between hours 0 and 2, any incidence of postoperative nausea and vomiting was not observed in 23 (76.7%) patients in Group P, 17 (56.7%) in Group D and 8 (26.7%) in Group C. Differences were observed between the groups in hours 0-2 and 2-8 in terms of verbal descriptive scale values for postoperative nausea and vomiting (p<0.01 and p=0.004, respectively). Total incidence rates of postoperative nausea and vomiting at hours 2-8 h were 10.0% (n=3) in Group P, 36.7% (n=11) in Group D and 53.3% (n=16) in Group C, the difference being statistically significant in favour of Group P (p=0.032). At 0-24. hrs, the number of patients vomiting, despite treatment, were lower in Groups P and D (n=4, 13.3% and n=5, 16.7%, respectively) compared to Group C (n=14, 46.7%) (p=0.005). Antiemetic use was higher in Group C than in Groups D and P (p=0.001). Intraoperative low-dose propofol infusion is as effective as dexamethasone in reducing the incidence and severity of postoperative nausea and vomiting, as well as reducing post-tympanoplasty antiemetic requirements. © 2017, Logos Medical Publishing. All rights reserved.
dc.identifier.doi10.5222/mmj.2017.085
dc.identifier.eissn2149-4606
dc.identifier.endpage90
dc.identifier.issn2149-2042
dc.identifier.issue2
dc.identifier.scopus2-s2.0-85044144340
dc.identifier.startpage85
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/14930
dc.identifier.volume32
dc.language.isoen
dc.publisherLogos Medical Publishing
dc.relation.ispartofMedeniyet Medical Journal
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectDexamethasone
dc.subjectPostoperative nausea and vomiting
dc.subjectPropofol
dc.subjectTympanoplasty
dc.titleThe effects of dexamethasone vs low doses of propofol infusion on postoperative nausea and vomiting in tympanoplasty surgery: A randomized, placebo-controlled, double-blinded study; [Timpanoplasti cerrahisinde postoperatif bulantı ve kusmaya deksametazon ile düşük doz propofol infüzyonunun etkilerinin karşılaştırılması: Randomize, plasebo-kontrollü, çift kör çalışma]
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus2
rdl.citation.trdizin1
rdl.departmentT.C. SAĞLIK BAKANLIĞI
rdl.departmentERZİNCAN BİNALİ YILDIRIM ÜNİVERSİTESİ
rdl.departmentATATÜRK ÜNİVERSİTESİ
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexTRDIZIN